Investing With IBD cover image

Ep. 119: Jim Golan: Building A High-Conviction Portfolio For The Long Haul

Investing With IBD

00:00

The Rise and Fall of Microsoft

Microsoft is on our long term leaders list at IBD. The five year annual compounded earnings growth rate is 20%, which is pretty incredible. Microsoft has tremendous relationships with their enterprise customers, unlike other tech companies. And it's been a terrific stock for the past seven or eight years for investors.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app